New Key Statistics Module, Z-Score and F-Score
NAS:VTGN Key Ratios
| Market Cap $ M | 74.90 |
| Enterprise Value $ M | -23.39 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.78 |
| Price/Sales | 89.33 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -1.34 |
| Beneish M-Score | -2.95 |
| 10-y EBITDA Growth Rate % | 34.70 |
| 5-y EBITDA Growth Rate % | 34.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.51 |
| EV-to-EBITDA | 0.52 |
| PEG | -- |
| Shares Outstanding M | 27.84 |
| Net Margin (%) | -4,521.71 |
| Operating Margin % | -5,211.54 |
| Pre-tax Margin (%) | -4,520.80 |
| Quick Ratio | 13.29 |
| Current Ratio | 13.29 |
| ROA % (ttm) | -38.57 |
| ROE % (ttm) | -42.00 |
| ROIC % (ttm) | -852.87 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.81 |
VTGN Number of Guru Trades
VTGN Volume of Guru Trades
Gurus Latest Trades with NAS:VTGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VTGN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Vistagen Therapeutics Inc Insider Transactions
No Available Data
News about NAS:VTGN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers